Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Relative Inactivity of Alpha-1-antitrypsin After Bone Marrow Transplantation as a Dynamic Biomarker for GVHD and Prognosis: a Prospective Cohort Study

NCT03188601 is registered in ClinicalTrials.gov with Rambam Health Care Campus as lead sponsor.

NCT NCT03188601
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03188601 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Relative Inactivity of Alpha-1-antitrypsin After Bone Marrow Transplantation as a Dynamic Biomarker for GVHD and Prognosis: a Prospective Cohort Study
Lead sponsor
Rambam Health Care Campus
Phase
Observational
Overall status
Completed
Start date
January 27, 2018
Completion date
August 1, 2022
Enrollment
27 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

alpha 1-antitrypsin, bone marrow transplant failure, gvhd